Monday January 17th, 2022 2:55AM
12:00AM ( 2 hours ago ) News Alert

US: AstraZeneca results may have included outdated info

By The Associated Press
Related Articles
  Contact Editor

WASHINGTON (AP) — AstraZeneca may have included “outdated information” in touting the effectiveness of its COVID-19 vaccine in a U.S. study, federal health officials said Tuesday in an unusual public rift that could further erode confidence in the shot.

In response, AstraZeneca said that it is working on more up-to-date information and that the more recent findings are consistent with the earlier ones. It promised an update within 48 hours.

It was not clear exactly what concerns U.S. health officials have. But the unprecedented tension erupted just hours after AstraZeneca released information it hoped would help settle lingering questions about the effectiveness of a vaccine that is being widely used in Europe and other parts of the world and is about to be considered for use in the U.S.

The company announced on Monday that a predominantly U.S. study of 32,000 volunteers showed its vaccine was 79% effective in preventing symptomatic COVID-19 disease. It also stressed there were no severe illnesses or hospitalizations among volunteers given the vaccine, compared with five cases among those given dummy shots.

But shortly after midnight, the National Institutes of Health issued a statement saying the independent monitors that oversee the study had “expressed concern that AstraZeneca may have included outdated information from that trial, which may have provided an incomplete view of the efficacy data.”

The NIH urged the company to “ensure the most accurate, up-to-date efficacy data be made public as quickly as possible.”

Outside experts were surprised and puzzled by the spat. But they noted that ultimately the Food and Drug Administration will scrutinize all the data before deciding whether AstraZeneca's vaccine can be rolled out in the U.S.

“It would seem that whatever this communication misstep is, at the end of the day the data will have to stand for itself,” said Dr. Jesse Goodman of Georgetown University, a former FDA vaccine chief.

The NIH's Dr. Anthony Fauci told ABC's “Good Morning America” that the incident “really is what you call an unforced error" and that he expects the discrepancy to be straightened out.

Fauci also said the episode shows the U.S. regulatory system is working: “The data and safety monitoring board picking up this discrepancy was an example of a safeguard.”

But that nitty-gritty seldom is seen by the public, something now exposed by the extraordinary microscope being applied to development of the world's COVID-19 vaccines.

Every vaccine trial is overseen by a “data and safety monitoring board,” or DSMB. These boards include scientists and statisticians who are experts in their fields but have no ties to either the government or the vaccine makers.

In the AstraZeneca study, just like studies of the other vaccines in use, some participants get the real vaccine and the rest get dummy shots, and neither they nor their doctors know which is which. Only the DSMB has the power to unlock the code of who got which and peek at how the volunteers are faring before a study is finished.

The DSMB watches for safety concerns and also deems when the study has met pre-determined endpoints showing it's time for an effectiveness calculation. It was the NIH-appointed DSMB that raised the concerns about AstraZeneca's data.

On Tuesday, AstraZeneca said that the data it first released included COVID-19 cases that occurred up to Feb. 17, as the study rules specified, and that it is continuing to analyze cases that have occurred since then. It said a preliminary analysis of more recent data was consistent with what it had already reported.

It is common for companies developing COVID-19 vaccines to release early data and to continue studying results as they come in.

Some experts had hoped that Monday's AstraZeneca announcement would help rebuild public confidence in the shot around the world.

The vaccine is used widely in Britain, across the European continent and in other countries, but its rollout was troubled by inconsistent study reports about its effectiveness, and then last week a scare about blood clots that had some countries temporarily pausing inoculations.

The U.S. study findings announced by AstraZeneca were consistent with studies from elsewhere — and real-world use in Britain — that found the vaccine offers good protection against the worst COVID-19 has to offer. But company executives refused repeated requests from reporters to provide a breakdown of the 141 COVID-19 cases it was using to make the case for the shot's effectiveness.

The company has said it aims to file an application with the FDA in the coming weeks.

  • Associated Categories: U.S. News, Associated Press (AP), AP National News, Top U.S. News short headlines, Top General short headlines, AP Health, AP Business, AP Business - Corporate News, AP Business - Industries, AP Business - Health Care
© Copyright 2022
All rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.
US: AstraZeneca results may have included outdated info
American federal health officials say results from a U.S. trial of AstraZeneca’s COVID-19 vaccine may have included “outdated information” and that could mean the company provided an incomplete view of efficacy data
9:23AM ( 2 minutes ago )
AP-NORC poll: Learning setbacks a top concern for parents
A new poll finds most parents fear their children are falling behind in school while at home during the coronavirus pandemic
9:23AM ( 3 minutes ago )
California bill aims to jumpstart 'microstamps' on handguns
California could expand its unique law requiring individual identifiers on all bullet casings to include weapons used by law enforcement
9:13AM ( 13 minutes ago )
Associated Press (AP)
Sinovac says its vaccine is safe for children as young as 3
Sinovac says its COVID-19 vaccine is safe in children ages 3-17, based on preliminary data, and it has submitted the data to Chinese drug regulators
8:50AM ( 35 minutes ago )
The Latest: Dr. Fauci warns of possible virus surge in US
Dr Anthony Fauci is warning a surge of coronavirus cases in Europe could foreshadow a similar surge in the United States
8:41AM ( 45 minutes ago )
Xi, Kim share messages reaffirming China-N. Korea alliance
The leaders of China and North Korea are reaffirming their traditional alliance following contentious talks between top diplomats from Washington and Beijing and ongoing diplomatic isolation and economic problems in the North that have left it ever-more dependent on the Chinese
8:36AM ( 49 minutes ago )
AP Business
Overstimulated? Stocks soar 75% in historic 12-month run
It was one year ago that the terrifying free fall for the stock market suddenly ended, ushering in one of its greatest runs
5:32AM ( 3 hours ago )
The Latest: EU slams AstraZeneca for production shortfalls
A leading European Union official has lashed out at the AstraZeneca vaccine company for its massive shortfall in producing doses for the EU
5:26AM ( 3 hours ago )
Asian stocks fall after Wall St rises on tech gains
Asian stock markets have fallen after Wall Street rose on gains for tech companies and the U.S. Federal Reserve's promise of support for an economic recovery
2:05AM ( 7 hours ago )
AP Business - Industries
Technology companies lead stocks higher on Wall Street
Gains in big technology companies led stocks broadly higher on Wall Street as traders welcomed some easing in long-term bond yields
4:39PM ( 16 hours ago )
AstraZeneca: US data shows vaccine effective for all adults
AstraZeneca says that its COVID-19 vaccine provided strong protection among all adults in a long-anticipated U.S. study
2:56PM ( 18 hours ago )
Tech leads stocks higher as bond yields ease; banks fall
Stocks are headed higher in afternoon trading Monday as a modest drop in bond yields helps lift the broader market
2:30PM ( 18 hours ago )
AP Business - Health Care
California bill aims to jumpstart 'microstamps' on handguns
California could expand its unique law requiring individual identifiers on all bullet casings to include weapons used by law enforcement
9:13AM ( 13 minutes ago )
Israel votes: Netanyahu's fate hangs on Tuesday's elections
Israelis are voting in a highly charged election considered a referendum on Prime Minister Benjamin Netanyahu
9:06AM ( 20 minutes ago )
George C. Wolfe, Anne Carson win PEN achievement awards
Tony Award winner George C
9:00AM ( 26 minutes ago )
Colorado shooting leaves 10 dead in latest mass tragedy
Police say 10 people have been killed in a shooting at a Colorado supermarket, including a police officer
8:55AM ( 31 minutes ago )
Sinovac says its vaccine is safe for children as young as 3
Sinovac says its COVID-19 vaccine is safe in children ages 3-17, based on preliminary data, and it has submitted the data to Chinese drug regulators
8:50AM ( 35 minutes ago )